Sponsor:
Tovah Burstein
Code:
NCT03231644
Conditions
Fibrous Dysplasia
McCune Albright Syndrome
Mazabraud Syndrome
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Fibrous Dysplasia
McCune Albright Syndrome
Mazabraud Syndrome
Study ID
NCT03231644
Start date
Oct 31, 2016
Status verified date
Aug, 2025
Completion date
Oct, 2028
Anticipated
Primary completion date
Oct, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
600 participants
Anticipated
Arms
FD/MAS Patients
Primary outcome measure
Central contacts
Carmel Shemmesh-Rafalowsky
PI.Registry@fibrousdysplasia.orgLocations
Tovah Burstein
Recruiting
Bethesda, Maryland, United States, 20816-2558
Contacts
Sponsor
Tovah Burstein
Last update posted
Aug 12, 2025
Last verified
Aug, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Tovah Burstein on 2025-08-12.